PINK1 parkinsonism and Parkinson disease: Distinguishable brain mitochondrial function and metabolomics

Mitochondrion

Volumn 13, Issue 1, 2013, Pages 59-61

  Rango, M ^a   Arighi, A ^a   Marotta, G ^a   Ronchi, D ^a   Bresolin, N ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Mitochondria; MRS; Parkinson; PET; PINK1; Resting state connectivity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; FLUORODEOXYGLUCOSE F 18; LEVODOPA; PRAMIPEXOLE; ROTIGOTINE; SERTRALINE;

ADULT; AKINESIA; ARTICLE; BRAIN MITOCHONDRION; CASE REPORT; CLINICAL FEATURE; COMPULSION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; FEMALE; GAIT DISORDER; GENE; HAND TREMOR; HUMAN; HYPERREFLEXIA; METABOLOMICS; MOLECULAR PATHOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PATIENT ASSESSMENT; PINK1 GENE; PRIORITY JOURNAL; TORSION DYSTONIA; TREATMENT RESPONSE; URINARY URGENCY;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; MIDDLE AGED; MITOCHONDRIA; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN KINASES;

EID: 84873271094     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.10.004     Document Type: Article

References (14)

1. Albanese A., Valente E.M., Romito L.M., Bellacchio E., Elia A.E., Dallapiccola B. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology 2005, 64(11). (Jun 14).
2. Bonifati V., Rohé C.F., Breedveld G.J., et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 2005, 65(1):87-95. (Jul 12).
3. Borghammer P., Chakravarty M., Jonsdottir K.Y., et al. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct. Funct. 2010, 214(4):303-317. (May).
4. Cilia R., Righini A., Marotta G., et al. Clinical and imaging characterization of a patient with idiopathic progressive ataxia and palatal tremor. Eur. J. Neurol. 2007, 14(8):944-946. (Aug).
5. Del Bo R., Moggio M., Rango M., et al. Mutated mitofusin 2 presents with intrafamilial variability and brain mitochondrial dysfunction. Neurology 2008, 71(24):1959-1966. (Dec 9).
6. Gautier C.A., Kitada T., Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(32):11364-11369. (Aug 12, Epub 2008 Aug 7).
7. Heeman B., Van den Haute C., Aelvoet S.A., et al. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. J. Cell Sci. 2011, 124(Pt 7):1115-1125. (Apr 1).
8. Kushner M., Nencini P., Reivich M., Rango M., et al. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann. Neurol. 1990, 28(2):129-135. (Aug).
9. Leech R., Braga R., Sharp D.J. Echoes of the brain within the posterior cingulate cortex. J. Neurosci. 2012, 32(1):215-222. (Jan 4).
10. Liu W., Acín-Peréz R., Geghman K.D., Manfredi G., Lu B., Li C. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(31):12920-12924. (Aug 2).
11. Rango M., Bozzali M., Prelle A., Scarlato G., Bresolin N. Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study. J. Cereb. Blood Flow Metab. 2001, 21(1):85-91. (Jan).
12. Rango M., Bonifati C., Bresolin N. Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study. J. Cereb. Blood Flow Metab. 2006, 26(2):283-290. (Feb).
13. Rango M., Cogiamanian F., Marceglia S., et al. Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: a 1H-MRS study. Magn. Reson. Med. 2008, 60(4):782-789. (Oct).
14. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., González-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304(5674):1158-1160. (May 21).